Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-25 @ 10:50 PM
Study NCT ID:
NCT00440167
Status:
UNKNOWN
Last Update Posted:
2012-07-09
First Post:
2007-02-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine
Sponsor:
PD Dr. med. Volker Heinemann
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
2011-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-12
Completion Date Type:
ESTIMATED
First Submit Date:
2007-02-22
First Submit QC Date:
None
Study First Post Date:
2007-02-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-07-05
Last Update Post Date:
2012-07-09
Last Update Post Date Type:
ESTIMATED